Santen Pharmaceutical Co Stock Price on September 26, 2024
SNPHF Stock | USD 10.53 0.62 5.56% |
If you're considering investing in Santen Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Santen Pharmaceutical stands at 10.53, as last reported on the 14th of December 2024, with the highest price reaching 10.53 and the lowest price hitting 10.53 during the day. Santen Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0248, which indicates the firm had a -0.0248% return per unit of risk over the last 3 months. Santen Pharmaceutical Co exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Santen Pharmaceutical's Variance of 5.18, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,015) to confirm the risk estimate we provide.
Santen Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Santen |
Sharpe Ratio = -0.0248
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | SNPHF |
Estimated Market Risk
2.28 actual daily | 20 80% of assets are more volatile |
Expected Return
-0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Santen Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Santen Pharmaceutical by adding Santen Pharmaceutical to a well-diversified portfolio.
Related Headline
Grifols SA Headline on 26th of September 2024
Head-To-Head Review Provectus Biopharmaceuticals and Grifols by thelincolnianonline.com
Grifols and Provectus Biopharmaceuticals are both medical companies, but which is the better stock We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations. Institutional and Insider Ownership 0.1 percent of Provectus Biopharmaceuticals shares
Santen Pharmaceutical Valuation on September 26, 2024
It is possible to determine the worth of Santen Pharmaceutical on a given historical date. On September 26, 2024 Santen was worth 11.7 at the beginning of the trading date compared to the closed value of 11.7. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Santen Pharmaceutical pink sheet. Still, in general, we apply an absolute valuation method to find Santen Pharmaceutical's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Santen Pharmaceutical where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Santen Pharmaceutical's related companies.
Open | High | Low | Close | Volume | |
11.65 | 11.65 | 11.65 | 11.65 | 1.00 | |
09/26/2024 | 11.70 | 11.70 | 11.70 | 11.70 | 378.00 |
11.83 | 11.83 | 11.83 | 11.83 | 1.00 |
Backtest Santen Pharmaceutical | | | Santen Pharmaceutical History | | | Santen Pharmaceutical Valuation | Previous | Next |
Santen Pharmaceutical Trading Date Momentum on September 26, 2024
On September 30 2024 Santen Pharmaceutical Co was traded for 11.83 at the closing time. The highest daily price throughout the period was 11.83 and the lowest price was 11.83 . There was no trading activity during the period 1.0. Lack of trading volume on 09/30/2024 added to the next day price rise. The trading price change to closing price of the next trading day was 1.11% . The trading price change to current closing price is 5.13% . |
Santen Pharmaceutical Fundamentals Correlations and Trends
By evaluating Santen Pharmaceutical's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Santen Pharmaceutical's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Santen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Santen Pharmaceutical Pink Sheet history
Santen Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Santen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Santen Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Santen Pharmaceutical stock prices may prove useful in developing a viable investing in Santen Pharmaceutical
Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices in Japan and internationally. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan. Santen Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 4315 people.
Santen Pharmaceutical Pink Sheet Technical Analysis
Santen Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Santen Pharmaceutical Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
Santen Pharmaceutical Co cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Santen Pharmaceutical December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how Santen Pharmaceutical pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Santen Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Santen Pharmaceutical pink sheet market strength indicators, traders can identify Santen Pharmaceutical Co entry and exit signals to maximize returns
Santen Pharmaceutical Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Santen Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Santen Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Santen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.03) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.41) | |||
Treynor Ratio | (0.53) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Transaction History View history of all your transactions and understand their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |